Skip Nav Destination
Roles for SGLT2 Inhibitors in Cardiorenal Disease
Cardiorenal Med (2022) 12 (3): 81–93.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
- Asma Mousavi
- Shayan Shojaei
- Hamidreza Soleimani
- Davood Semirani-Nezhad
- Pouya Ebrahimi
- Ali Zafari
- Rasoul Ebrahimi
- Khatere Roozbehi
- Anil Harrison
- Mushabbar A. Syed
- Toshiki Kuno
- Mani Khorsand Askari
- Jaime P. Almandoz
- John Jun
- Kaveh Hosseini
Diabetology & Metabolic Syndrome (2025) 17 (1)
- Alfredo Caturano
- Raffaele Galiero
- Maria Rocco
- Giuseppina Tagliaferri
- Alessia Piacevole
- Davide Nilo
- Giovanni Di Lorenzo
- Celestino Sardu
- Vincenzo Russo
- Erica Vetrano
- Marcellino Monda
- Raffaele Marfella
- Luca Rinaldi
- Ferdinando Carlo Sasso
Biomolecules (2024) 14 (11): 1393.
- Corina T. Madreiter-Sokolowski
- Ursula Hiden
- Jelena Krstic
- Katrin Panzitt
- Martin Wagner
- Christian Enzinger
- Michael Khalil
- Mahmoud Abdellatif
- Ernst Malle
- Tobias Madl
- Elena Osto
- Markus Schosserer
- Christoph J. Binder
- Andrea Olschewski
Pharmacology & Therapeutics (2024) 262: 108710.
- Qin Zhang
- Siyuan Zhou
- Lijun Liu
Diabetology & Metabolic Syndrome (2023) 15 (1)
- Alberto Calderón Montero
Medicina de Familia. SEMERGEN (2023) 49: 102019.
- Carlos Escobar
- Domingo Pascual-Figal
- Luis Manzano
- Julio Nuñez
- Miguel Camafort
Journal of Clinical Medicine (2023) 12 (21): 6798.
- Alberto Palazzuoli
- Michele Correale
- Massimo Iacoviello
- Edoardo Gronda
Journal of Clinical Medicine (2023) 12 (2): 693.
- Cheng-Yang Hsieh
- Sheng-Feng Sung
International Journal of Molecular Sciences (2022) 24 (1): 351.
